Crossmark

Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction

Crossref DOI link: https://doi.org/10.1186/s12935-020-01651-8

Published Online: 2020-11-19

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xing, Linlin http://orcid.org/0000-0003-0554-0367
Xia, Mengyan

Jiao, Xin

Fan, Ling
License Information

Text and Data Mining valid from 2020-11-19

Version of Record valid from 2020-11-19
More Information

Article History

Received: 6 August 2020

Accepted: 9 November 2020

First Online: 19 November 2020

Ethics approval and consent to participate

: Informed consent forms have been signed by all patients before this study. The research protocol has been approved by the Ethics Committee of the Shengjing Hospital of China Medical University and is based on the ethical principles of medical research involving human subjects in the Helsinki Declaration (No.:2018PS362K).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below